PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells (vol 1839, pg 88, 2014)

被引：0
|
作者：
Wu, Gengze [1 ]
Liu, Dongbo [1 ]
Jiang, Ke [3 ]
Zhang, Li [1 ]
Zeng, Yijun [1 ]
Zhou, Peng [1 ]
Zhong, Dan [1 ]
Gao, Min [1 ]
He, Fengtian [1 ]
Zheng, Yingru [2 ]
机构：
[1] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing 400038, Peoples R China
[2] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Obstet & Gynecol, Chongqing 400042, Peoples R China
[3] PLA, Hosp 324, Dept Clin Lab 1, Chongqing 400020, Peoples R China
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS | 2015年 / 1849卷 / 03期
关键词：
D O I：
10.1016/j.bbagrm.2014.07.014
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [1] PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells
    Wu, Gengze
    Liu, Dongbo
    Jiang, Ke
    Zhang, Li
    Zeng, Yijun
    Zhou, Peng
    Zhong, Dan
    Gao, Min
    He, Fengtian
    Zheng, Yingru
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2014, 1839 (02): : 88 - 96
  • [2] P53 INACTIVATION BY HPV16 E6 RESULTS IN INCREASED MUTAGENESIS IN HUMAN-CELLS
    HAVRE, PA
    YUAN, JL
    HEDRICK, L
    CHO, KR
    GLAZER, PM
    CANCER RESEARCH, 1995, 55 (19) : 4420 - 4424
  • [3] Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53
    A Reschner
    S Bontems
    S Le Gac
    J Lambermont
    L Marcélis
    E Defrancq
    P Hubert
    C Moucheron
    A Kirsch-De Mesmaeker
    M Raes
    J Piette
    P Delvenne
    Gene Therapy, 2013, 20 : 435 - 443
  • [4] Ruthenium oligonucleotides, targeting HPV16 E6 oncogene, inhibit the growth of cervical cancer cells under illumination by a mechanism involving p53
    Reschner, A.
    Bontems, S.
    Le Gac, S.
    Lambermont, J.
    Marcelis, L.
    Defrancq, E.
    Hubert, P.
    Moucheron, C.
    Kirsch-De Mesmaeker, A.
    Raes, M.
    Piette, J.
    Delvenne, P.
    GENE THERAPY, 2013, 20 (04) : 435 - 443
  • [5] Immune response to p53 and HPV-16 E6 proteins in patients with cervical cancer
    Park, JS
    Kim, CJ
    Um, SJ
    Hwang, ES
    Kim, HS
    Park, SN
    Namkoong, SE
    Kim, SJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (04) : 328 - 335
  • [6] Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 e6 containing SiHa cells
    Huang, HM
    Huang, SY
    Chen, TT
    Chen, JC
    Chiou, CL
    Huang, TM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2004, 91 (04) : 756 - 765
  • [7] Novel Affibody Molecules Targeting the HPV16 E6 Oncoprotein Inhibited the Proliferation of Cervical Cancer Cells
    Zhu, Jinshun
    Kamara, Saidu
    Wang, Qi
    Guo, Yanru
    Li, Qingfeng
    Wang, Linlin
    Chen, Jingjing
    Du, Qianqian
    Du, Wangqi
    Chen, Shao
    Zhu, Shanli
    Chen, Jun
    Chu, Maoping
    Zhang, Lifang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [8] Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers
    Reuschenbach, Miriam
    Waterboer, Tim
    Wallin, Keng-Ling
    Einenkel, Jens
    Dillner, Joakim
    Hamsikova, Eva
    Eschenbach, Denise
    Zimmer, Heike
    Heilig, Bernhard
    Kupitz, Juergen
    Pawlita, Michael
    Doeberitz, Magnus von Knebel
    Wentzensen, Nicolas
    INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (11) : 2626 - 2631
  • [9] Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation
    Huang, H
    Li, CY
    Little, JB
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1996, 70 (02) : 151 - 160
  • [10] E6/E7 and E6*From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
    Artaza-Irigaray, Cristina
    Molina-Pineda, Andrea
    Aguilar-Lemarroy, Adriana
    Ortiz-Lazareno, Pablo
    Limon-Toledo, Laura P.
    Pereira-Suarez, Ana L.
    Rojo-Contreras, Wendoline
    Jave-Suarez, Luis F.
    FRONTIERS IN IMMUNOLOGY, 2019, 10 : 1676
12345